Statistical Decision Properties of Imprecise Trials Assessing Coronavirus Disease 2019 (COVID-19) Drugs

OBJECTIVES: Researchers studying treatment of coronavirus disease 2019 (COVID-19) have reported findings of randomized trials comparing standard care with care augmented by experimental drugs. Many trials have small sample sizes, so estimates of treatment effects are imprecise. Hence, clinicians may...

Descripción completa

Detalles Bibliográficos
Autores principales: Manski, Charles F., Tetenov, Aleksey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. 2021
Materias:
Themed Section: COVID-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942186/
https://www.ncbi.nlm.nih.gov/pubmed/33933232
http://dx.doi.org/10.1016/j.jval.2020.11.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942186/
https://www.ncbi.nlm.nih.gov/pubmed/33933232
http://dx.doi.org/10.1016/j.jval.2020.11.019

Ejemplares similares